HomeCNTX • NASDAQ
add
Context Therapeutics Inc
Previous close
$1.00
Day range
$0.92 - $1.00
Year range
$0.55 - $2.73
Market cap
84.32M USD
Avg Volume
214.58K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.31M | -37.83% |
Net income | -3.34M | 50.62% |
Net profit margin | — | — |
Earnings per share | 0.00 | 100.00% |
EBITDA | -4.31M | 37.85% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 94.43M | 553.50% |
Total assets | 98.13M | 510.90% |
Total liabilities | 2.86M | -31.76% |
Total equity | 95.27M | — |
Shares outstanding | 89.70M | — |
Price to book | 0.94 | — |
Return on assets | -11.68% | — |
Return on capital | -12.00% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -3.34M | 50.62% |
Cash from operations | -4.91M | 32.11% |
Cash from investing | 0.00 | — |
Cash from financing | 14.54M | — |
Net change in cash | 9.63M | 233.22% |
Free cash flow | -4.24M | 11.43% |
About
Founded
2015
Headquarters
Website
Employees
12
